시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 근이완제 시장 규모, 점유율, 성장 분석 : 약제 클래스별, 투여 경로별, 유통 채널별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Muscle Relaxant Drugs Market Size, Share, and Growth Analysis, By Drug Class, By Route of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032
상품코드 : 1681601
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,657,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,957,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,258,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

근이완제 2023년 시장 규모는 48억 달러, 2024년 50억 7,000만 달러에서 2032년에는 79억 1,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 5.7%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

근이완제 시장은 근육과 관련된 문제를 해결하는 데 있어 효능을 향상시키는 혁신적인 제제를 도입함으로써 혁신적인 변화를 목격하고 있습니다. 제조업체들은 제품의 매력과 신뢰성을 보장하기 위해 고품질 포장과 디자인에 집중하고 있습니다. 경쟁 환경은 소비자의 관심을 끌기 위해 필수적인 규제 승인과 광범위한 시장 유통에 의해 점점 더 촉진되고 있습니다. 소비자들 사이에서 근육 건강에 대한 인식이 계속 높아짐에 따라 효과적인 근이완제에 대한 수요가 증가할 것으로 예상됩니다. 이러한 추세는 근이완제 부문의 미래가 유망하다는 것을 보여주며, 정보에 입각한 소비자 선택과 진화하는 건강 요구에 부응하는 혁신적인 제품 제공으로의 전환을 강조하고 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

근이완제 시장 규모 : 약제 클래스별&CAGR(2025-2032년)

근이완제 시장 규모 : 투여 경로별&CAGR(2025-2032년)

근이완제 시장 규모 : 유통 채널별&CAGR(2025-2032년)

근이완제 시장 규모 : 최종사용자별&CAGR(2025-2032년)

근이완제 시장 규모 : 지역별&CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 제안

LSH
영문 목차

영문목차

Muscle Relaxant Drugs Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.07 billion in 2024 to USD 7.91 billion by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The muscle relaxant pill market is witnessing a transformative shift as companies introduce innovative formulations that enhance efficacy in addressing muscle-related issues. To ensure product appeal and trustworthiness, manufacturers are focusing on high-quality packaging and design. The competitive landscape is increasingly driven by regulatory approvals and widespread market distribution, which are essential for capturing consumer attention. As awareness about muscle health continues to grow among consumers, the demand for effective muscle relaxants is expected to rise. This trend indicates a promising future for the muscle relaxant drug segment, highlighting a shift towards informed consumer choices and innovative product offerings that address evolving health needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Muscle Relaxant Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Muscle Relaxant Drugs Market Segments Analysis

Global Muscle Relaxant Drugs Market is segmented by Drug Class, Route of Administration, Distribution Channel, End User and region. Based on Drug Class, the market is segmented into Neuromuscular Blocking Agents, Skeletal Muscle Relaxants and Others. Based on Route of Administration, the market is segmented into Oral and Parenteral. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and Others. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Muscle Relaxant Drugs Market

A significant driving force behind the muscle relaxant drugs market is the increasing population, particularly the aging demographic. As individuals grow older, they tend to experience a higher prevalence of muscle-related issues, including musculoskeletal disorders and muscle spasms. This rising incidence has led to a marked increase in the dependency on and demand for muscle relaxant medications. Consequently, it has become a common practice for older adults to incorporate these drugs into their daily routines to alleviate discomfort and manage pain effectively. This growing trend is expected to further propel the muscle relaxant drugs market in the coming years.

Restraints in the Muscle Relaxant Drugs Market

In the broad landscape of muscle relaxant medications, a significant barrier is the risk of side effects associated with these drugs. Muscle relaxants can lead to various adverse reactions, including dizziness, drowsiness, and impaired motor coordination. This raises concerns regarding safety, particularly in situations that require full attention, such as driving. The potential for these side effects limits the extensive use of muscle relaxants, especially among certain populations, necessitating healthcare providers to approach their prescription with careful consideration. As such, the presence of these side effects hinders the overall acceptance and utilization of muscle relaxant therapies in clinical practice.

Market Trends of the Muscle Relaxant Drugs Market

The Muscle Relaxant Drugs market is witnessing a significant trend towards non-sedative formulations, driven by growing patient and healthcare provider preferences for medications that relieve muscle tension without the side effects of drowsiness. This shift reflects a broader desire for treatments that support an active lifestyle and improve overall quality of life, particularly in professions requiring high levels of alertness and productivity. As a result, pharmaceutical companies are increasingly focusing on developing and marketing muscle relaxants with enhanced safety profiles and reduced sedative effects. This strategic realignment aims to cater to the evolving needs of consumers, ultimately shaping the future landscape of the muscle relaxant drug market.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Muscle Relaxant Drugs Market Size by Drug Class & CAGR (2025-2032)

Global Muscle Relaxant Drugs Market Size by Route of Administration & CAGR (2025-2032)

Global Muscle Relaxant Drugs Market Size by Distribution Channel & CAGR (2025-2032)

Global Muscle Relaxant Drugs Market Size by End User & CAGR (2025-2032)

Global Muscle Relaxant Drugs Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기